Consensus on renovascular hypertension: diagnosis and treatment

The clinical significance of renovascular arterial hypertension is determined by it is high prevalence as well as it is negative impact on prognosis. The most common causes of renovascular arterial hypertension are atherosclerotic stenosis of the renal arteries and fibromuscular dysplasia. Renovascular arterial hypertension is characterized by the development of blood pressure resistant to antihypertensive therapy with an unfavorable prognosis of worsening renal function and cardiovascular complications. Currently, the most available screening method in the diagnosis of renovascular arterial hypertension is duplex scanning of the renal arteries. Non-invasive diagnostic methods also include magnetic resonance and multispiral computed tomography with intravenous contrast. Contrast angiography remains “the golden standard” for diagnosing renovascular arterial hypertension and determining the indications for surgical treatment. Together with the use of diagnostic techniques such as measurement of translesion pressure gradient and fractional blood flow reserve, it allows to assess the functional significance of renal artery stenosis. Treatment of renovascular arterial hypertension is a complex process aimed at normalization of blood pressure, improvement of renal function, as well as mortality and cardiovascular risk reduction. To date, the feasibility of endovascular treatment remains an open question. More often the preference is given to conservative treatment. The indications for renal artery revascularization are less obvious, available clinical guidelines and results of large trials are controversial.

1. Boutari C, Georgianou E, Sachinidis A, Katsimardou A, Christou K, Piperidou A, Karagiannis A. Renovascular Hypertension: Novel Insights. Curr Hypertens Rev. 2020;16(1):24-29. https://doi.org/10.2174/1573402115666190416153321

2. Aboyans V, Ricco J-B, Bartelink M-L, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018 Mar 1;39(9):763-816. PMID: 28886620. https://doi.org/10.1093/eurheartj/ehx095

3. Williams B, Mancia G, Spiering W, et al. ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018 Sep 1;39(33):3021-3104. PMID: 3016551. https://doi.org/10.1093/eurheartj/ehy339

4. Dobrek L. An Outline of Renal Artery Stenosis Pathophysiology-A Narrative Review. Life (Basel). 2021 Mar 7;11(3):208. PMID: 33799957. https://doi.org/10.3390/life11030208

5. Shilov E.M., Batyushkin M.M. Renovaskulyarnaya arterial'naya gipertenziya i ishemicheskaya bolezn' pochek. Nephrology. Clinical guidelines. Eds. EM. Shilov, А.V. Smirnov, N.L. Kozlovskaya. M.: GEOTАR-Media. 2016;449-460 (in Russ.). ISBN 978-5-9704-3714-8

6. Textor SC. Renal Arterial Disease and Hypertension. Med Clin North Am. 2017 Jan;101(1):65-79. PMID: 27884236. https://doi.org/10.1016/j.mcna.2016.08.010

7. Herrmann SM, Textor SC. Current Concepts in the Treatment of Renovascular Hypertension. Am J Hypertens. 2018 Jan 12;31(2):139-149. PMID: 28985335. https://doi.org/10.1093/ajh/hpx154

8. Subramanian R, White CJ, Rosenfield K, et al. Renal fractional flow reserve: A hemodynamic evaluation of moderate renal artery stenoses. Catheter Cardiovasc Interv. 2005;64:480-6. https://doi.org/10.1002/ccd.20318

9. Persu A, Canning C, Prejbisz A, et al. Beyond Atherosclerosis and Fibromuscular Dysplasia: Rare Causes of Renovascular Hypertension. Hypertension. 2021;78(4):898-911. https://doi.org/10.1161/HYPERTENSIONAHA.121.17004

10. Joseph G. Murphy, Margaret a. Lloyd (editors in chief). Associate Editors – Peter A. Brady, Lyle J. Olson, Raymond C. Shields. Mayo Clinic Cardiology. Concise Textbook, Fourth Edition. Mayo Clinic Scientific Press, Mayo Foundation for Medical Education and Research. 2013; Ch. 47, p. 470-474.

11. Olin JW, Froehlich J, Gu X, Bacharach JM, Eagle K, Gray BH, Jaff MR, Kim ES, Mace P, Matsumoto AH, et al. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation. 2012;125:3182–3190. https://doi.org/10.1161/CIRCULATIONAHA.112.091223

12. de Mast Q, Beutler JJ. The prevalence of atherosclerotic renal artery stenosis in risk groups: a systematic literature review. J Hypertens. 2009 Jul;27(7):1333-40. https://doi.org/10.1097/hjh.0b013e328329bbf4

13. Khatami MR. Ischemic nephropathy: more than a simple renal artery narrowing. Iran J Kidney Dis. 2013 Mar;7(2):82-100. PMID: 23485531.

14. Pappaccogli M, Di Monaco S, Warchoł-Celińska E, Lorthioir A, Amar L, Aparicio LS, Beauloye C, Bruno RM, Chenu P, de Leeuw P, et al; Euro- pean/International FMD Registry and Initiative (FEIRI), and the Working Group ‘Hypertension and the Kidney’ of the European Society of Hypertension (ESH). The European/International Fibromuscular Dysplasia Registry and Initiative (FEIRI)-clinical phenotypes and their predictors based on a cohort of 1000 patients. Cardiovasc Res. 2021;117:950–959. https://doi.org/10.1093/cvr/cvaa102

15. Savard S., Steichen O., Azarine A. et al. Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristics. Circulation. 2012;126:3062–9. https://doi.org/10.1161/circulationaha.112.117499

16. Plouin P.F., Perdu J. Fibromuscular dysplasia. Orphanet. J. Rare Dis. 2007; 2: 28.

17. Mukhin N.А., Fomin V.V. Atherosclerotic stenosis of the renal arteries. V kn.: Rukovodstvo po aterosklerozu i ishemicheskoj bolezni serdtsa. Ed. E.I. CHazov, V.V. Kukharchuk, S.А. Bojtsov. M.:Media Medica, 2007. p.248-273 (in Russ.). ISBN 978-5-903574-02-5

18. Bagh I, Olin JW, Froehlich JB, Kline-Rogers E, Gray B, Kim ESH, Sharma A, Weinberg I, Wells BJ, Gu X, et al. Association of multifocal fibromuscular dysplasia in elderly patients with a more benign clinical phenotype: data from the US Registry for Fibromuscular Dysplasia. JAMA Cardiol. 2018;3:756-760. https://doi.org/10.1001/jamacardio.2018.1638

19. Christlieb AR, Biber TU, Hickler RB. Studies on the role of angiotensin in experimental renovascular hypertension: an immunologic approach. J Clin Invest. 1969 Aug;48(8):1506-18. https://doi.org/10.1172/jci106117

20. McAreavey D., Brown, W. B., Murray G. D., Robertson J. I. S. Exchangeable Sodium in Goldblatt One-Kidney One-Clip Hypertension in the Rat. Clinical Science. 1984; 66(5):545–549. https://doi.org/10.1042/cs0660545

21. Textor S.C., Lerman L. Renovascular Hypertension and Ischemic Nephropathy. American Journal of Hypertension. 2010;23(11):1159–1169. https://doi.org/10.1038/ajh.2010.174

22. Abumoawad A, Saad A, Ferguson CM, Eirin A, Woollard JR, Herrmann SM, Hickson LJ, Bendel EC, Misra S, Glockner J, et al. Tissue hypoxia, inflammation, and loss of glomerular filtration rate in human atherosclerotic renovascular disease. Kidney Int. 2019;95:948–957. https://doi.org/10.1016/j.kint.2018.11.039

23. Brunner HR, Kirshman JD, Sealey JE, Laragh JH. Hypertension of renal origin: evidence for two different mechanisms. Science. 1971 Dec 24;174(4016):1344-6. https://doi.org/10.1126/science.174.4016.1344

24. Aksenova A.V., Sivakova O.A., Blinova N.V., Danilov N.M., Elfimova E.M., Kisliak O.A., Litvin A.Y., Oshchepkova E.V., Fomin V.V., Chikhladze N.M., Shelkova G.V., Chazova I.E. Russian Medical Society for Arterial Hypertension expert consensus. Resistant hypertension: detection and management. Terapevticheskii arkhiv. 2021;93(9):1018-1029. (in Russ.). https://doi.org/10.26442/00403660.2021.09.201007

25. Krijnen P. A Clinical Prediction Rule for Renal Artery Stenosis. Annals of Internal Medicine. 1998;129(9):705. https://doi.org/10.7326/0003-4819-129-9-199811010-00005

26. Iantorno M., Pola R., Schinzari F., Filice G., Mettimano M., Cardillo C., Melina D. Association between Altered Circadian Blood Pressure Profile and Cardiac End-Organ Damage in Patients with Renovascular Hypertension. Cardiology. 2003;100(3):114–119. https://doi.org/10.1159/000073911

27. Trinquart L, Mounier-Vehier C, Sapoval M, et al. Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia. A systematic review and metaanalysis. Hypertension. 2010;56:525– 532. https://doi.org/10.1161/hypertensionaha.110.152918

28. Clinical guidelines – Chronic kidney disease (CKD) – 2021-2022-2023 (06.24.2021) – Approved by the Ministry of Health of the Russian Federation (in Russ.).

29. Chazova I.E., Chikhladze N.M., Blinova N.V., Belaya Z.E., Danilov N.M., Elfimova E.M., Litvin A.Yu. Eurasian clinical guidelines for the diagnosis and treatment of secondary (symptomatic) forms of arterial hypertension (2022). Eurasian heart journal. 2023;(1):6-65. (in Russ.). https://doi.org/10.38109/2225-1685-2023-1-6-65

30. Fomin V.V., Kutyrina I.M., Shvetsov M.Yu. Ischemic kidney disease. In the book: Nephrology. National leadership. Сoncise edition. Ch. ed. N.A Mukhin. – M.: «GEOTAR-Media», 2014. p. 377-386 (in Russ.). ISBN 978-5-9704-3788-9

31. Bailey SR, Beckman JA, Dao TD, et al. ACC/AHA/SCAI/SIR/SVM 2018 Appropriate Use Criteria for Peripheral Artery Intervention: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Heart Association, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, and Society for Vascular Medicine. J Am Coll Cardiol. 2019 Jan 22;73(2):214-237. https://doi.org/10.1016/j.jacc.2018.10.002

32. AbuRahma AF, Yacoub M. Renal imaging: duplex ultrasound, computed tomography angiography, magnetic resonance angiography, and angiography. Semin Vasc Surg. 2013 Dec;26(4):134-43. https://doi.org/10.1053/j.semvascsurg.2014.06.001

33. Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ, Galanski M, Koch KM, Haller H. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med. 2001 Feb 8;344(6):410-7. https://doi.org/10.1056/nejm200102083440603

34. Chi YW, White CJ, Thornton S, Milani RV. Ultrasound velocity criteria for renal in-stent restenosis. J Vasc Surg. 2009 Jul;50(1):119-23. https://doi.org/10.1016/j.jvs.2008.12.066

35. Fananapazir G., McGahan J. P., Corwin M. T., Stewart S. L., Vu C. T., Wright L., Troppmann C. Screening for Transplant Renal Artery Stenosis: Ultrasound-Based Stenosis Probability Stratification. American Journal of Roentgenology. 2017;209(5):1064–1073. https://doi.org/10.2214/ajr.17.17913

36. Jennings C.G., Houston J.G., Severn A. et al. Renal artery stenosis-when to screen, what to stent? Curr Atheroscler Rep. 2014 Jun;16(6):416. https://doi.org/10.1007/s11883-014-0416-2

37. Prince M, Tafur JD, White CJ. When and How Should We Revascularize Patients With Atherosclerotic Renal Artery Stenosis? JACC Cardiovasc Interv. 2019 Mar 25;12(6):505-517. https://doi.org/10.1016/j.jcin.2018.10.023

38. Williams GJ, Macaskill P, Chan SF, Karplus TE, Yung W, Hodson EM, Craig JC. Comparative accuracy of renal duplex sonographic parameters in the diagnosis of renal artery stenosis: paired and unpaired analysis. AJR Am J Roentgenol. 2007 Mar;188(3):798-811. https://doi.org/10.2214/ajr.06.0355

39. Vasbinder GB, Nelemans PJ, Kessels AG, et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med. 2004;141:674-82. https://doi.org/10.7326/0003-4819-141-9-200411020-00007

40. Tan K.T., van Beek E.J., Brown P.W. et al. Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. Clin Radiol. 2002 Jul;57(7):617-24. https://doi.org/10.1053/crad.2002.0941

41. Bley T., Francois C., Schiebler M. Non-contrast-enhanced MRA of renal artery stenosis: validation against DSA in a porcine model. European Radiology. 2016;26(2):547–55. https://doi.org/10.1007/s00330-015-3833-x

42. Taylor AT, Jr., Fletcher JW, Nally JV, Jr., et al. Procedure guideline for diagnosis of renovascular hypertension. Society of Nuclear Medicine. J Nucl Med. 1998;39(7):1297-302. PMID: 9669414.

43. Klein A. J., Jaff M. R., Gray B. H., Aronow H. D., Bersin R. M., Diaz-Sandoval L. J., White C. J. SCAI appropriate use criteria for peripheral arterial interventions: An update. Catheterization and Cardiovascular Interventions. 2017; 90(4):E90–E110. https://doi.org/10.1002/ccd.27141

44. Safian RD. Renal artery stenosis. Prog Cardiovasc Dis. 2021 Mar-Apr;65:60-70. https://doi.org/10.1016/j.pcad.2021.03.003

45. Mangiacapra F, Trana C, Sarno G, et al. Translesional pressure gradients to predict blood pressure response after renal artery stenting in patients with renovascular hypertension. Circ Cardiovasc Interv 2010;3:537–42. https://doi.org/10.1161/circinterventions.110.957704

46. Salmon P, Brown MA. Renal artery stenosis and peripheral vascular disease: implications for ACE inhibitor therapy. Lancet. 1990;336:321. https://doi.org/10.1016/0140-6736(90)91865-8

47. Conlon PJ, Little MA, Pieper K, Mark DB. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int. 2001 Oct;60(4):1490-7. PMID: 11576364. https://doi.org/10.1046/j.1523-1755.2001.00953.x

48. Jean WJ, al-Bitar I, Zwicke DL, Port SC, Schmidt DH, Bajwa TK. High incidence of renal artery stenosis in patients with coronary artery disease. Cathet Cardiovasc Diagn. 1994 May;32(1):8-10. https://doi.org/10.1002/ccd.1810320103

49. Weber-Mzell D, Kotanko P, Schumacher M, Klein W, Skrabal F. Coronary anatomy predicts presence or absence of renal artery stenosis. A prospective study in patients undergoing cardiac catheterization for suspected coronary artery disease. Eur Heart J. 2002;23:1684-91. https://doi.org/10.1053/euhj.2002.3314

50. Harding MB, Smith LR, Himmelstein SI, et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992;2:1608–16. https://doi.org/10.1681/asn.v2111608

51. Rihal CS, Textor SC, Breen JF, et al. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc. 2002;77:309–16. https://doi.org/10.4065/77.4.309

52. Ghaffari S., Sohrabi B., Siahdasht R. B., Pourafkari L. Prevalence and predictors of renal artery stenosis in hypertensive patients undergoing coronary angiography. Hypertension Research. 2009;32(11):1009– 1014. https://doi/org/10.1038/hr.2009.149

53. Ritchie J, Green D, Chrysochou C, Chalmers N, et al. High-risk clinical presentations in atherosclerotic renovascular disease: prognosis and response to renal artery revascularization. Am J Kidney Dis. 2014 Feb;63(2):186-97. PMID: 24074824. https://doi.org/10.1053/j.ajkd.2013.07.020

54. Tafur-Soto J.D., White C.J. Renal artery stenosis. Cardiology Clinics. 2015;33(1):59–73. https://doi.org/10.1016/j.ccl.2014.09.006

55. Bavishi C, de Leeuw PW, MD, Messerli FH. Atherosclerotic Renal Artery Stenosis and Hypertension: Pragmatism, Pitfalls, and Perspective. Am J Med. 2016 Jun;129(6):635.e5-635.e14. PMID: 26522797. https://doi.org/10.1016/j.amjmed.2015.10.010

56. Van der Niepen P, Rossignol P, Lengele J-P, et al. Renal Artery Stenosis in Patients with Resistant Hypertension: Stent It or Not? Curr Hypertens Rep. 2017;19(1):5. PMID: 28150134. https://doi.org/10.1007/s11906-017-0703-8

57. Hackam D.G., Spence J.D., Garg A.X. et al. Role of renin-angiotensin system blockade in atherosclerotic renal artery stenosis and renovascular hypertension. Hypertension. 2007 Dec;50(6):998-1003. https://doi.org/10.1161/HYPERTENSIONAHA.107.097345

58. Balafa O., Kalaitzidis R., Siamopoulos K.C. Optimal medical management in patients with renovascular hypertension. Am J Cardiovasc Drugs. 2013 Apr;13(2):71-8. https://doi.org/10.1007/s40256-013-0011-x

59. Kobalava Z.D., Konradi A.O., Nedogoda S.V., Shlyakhto E.V., Arutyunov G.P., Baranova E.I., Barbarash O.L., Boitsov S.A., et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):3786. (In Russ.). https://cr.minzdrav.gov.ru/schema/62_2 https://doi.org/10.15829/1560-4071-2020-3-3786

60. Manaktala R., Tafur-Soto J.D., White C.J. Renal Artery Stenosis in the Patient with Hypertension: Prevalence, Impact and Management. Integr Blood Press Control. 2020 Jun 2;13:71-82. https://doi.org/10.2147/IBPC.S248579

61. Herrmann SM, Textor SC. Renovascular Hypertension. Endocrinol Metab Clin North Am. 2019 Dec;48(4):765-778. https://doi.org/10.1016/j.ecl.2019.08.007

62. Rossi G. P., Bisogni V., Rossitto G., Maiolino G., Cesari M., Zhu R., and Seccia T. M. Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension. High Blood Pressure and Cardiovascular Prevention. 2020;27(6):547-560. https://doi.org/:10.1007/s40292-020-00415-9

63. Chikhladze N.M. Current trends in the use of the renin-angiotensin system blocking drugs in renovascular arterial hypertension. Systemic Hypertension. 2022;19(1):49-54. (In Russ.). https://doi.org/10.38109/2075-082X-2022-1-49-54

64. Sleight P. The HOPE Study (Heart Outcomes Prevention Evaluation). J Renin Angiotensin Aldosterone Syst. 2000 Mar;1(1):18-20. https://doi.org/10.3317/jraas.2000.002

65. Fox KM; EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003 Sep 6;362(9386):782-788. https://doi.org/10.1016/s0140-6736(03)14286-9

66. Kukharchuk V.V., Ezhov M.V., Sergienko I.V., et al. Eurasian Association Of Cardiology (EAC)/ Russian National Atherosclerosis Society (RNAS, Russia) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2020). Eurasian heart journal. 2020;(2):6-29. (In Russ.). https://doi.org/10.38109/2225-1685-2020-2-6-29

67. P.F. Plouin, G.Chatellier, B.Darné, A.Raynaud. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension. 1998 Mar;31(3):823-9. https://doi.org/10.1161/01.hyp.31.3.823

68. ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Russian Journal of Cardiology. 2018;(8):164-221. (In Russ.). https://doi.org/10.15829/1560-4071-2018-8-164-221

69. Bax L, Woittiez AJ, Kouwenberg HJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med. 2009;150:840–848 W150-1. https://doi.org/10.7326/0003-4819-150-12-200906160-00119

70. ASTRAL Investigators; Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, Carr S, Chalmers N, Eadington D, Hamilton G, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361:1953–1962. https://doi.org/10.1056/NEJMoa0905368

71. Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, Cohen DJ, Matsumoto AH, Steffes M, Jaff MR, et al; CORAL Investigators. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014;370:13–22. https://doi.org/10.1056/nejmoa1310753

72. White CJ. The "chicken little" of renal stent trials: the CORAL trial in perspective. JACC Cardiovasc Interv. 2014 Jan;7(1):111-3. https://doi.org/10.1016/j.jcin.2013.12.002

73. Rocha-Singh K, Jaff MR, Rosenfield K, for the ASPIRE 2 Investigators. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study. J Am Coll Cardiol. 2005;46:776–83. https://doi.org/10.1016/j.jacc.2004.11.073

74. Jaff MR, Bates M, Sullivan T, et al. Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial. Catheter Cardiovasc Interv. 2012;80:343–50. https://doi.org/10.1002/ccd.24449

75. Osami Kawarada, Yoshiaki Yokoi, Nobuyuki Morioka, Shinji Shiotani, Akihiro Higashimori. Cardiac benefits of renal artery stenting. EuroIntervention. 2010 Sep;6(4):485-91. PMID: 20884436. https://doi.org/10.4244/eij30v6i4a81

76. Zhu Y, Ren J, Ma X, Chen MH, Zhou Y, Jin M, Liu Z. Percutaneous Revascularization for Atherosclerotic Renal Artery Stenosis: A Meta-Analysis of Randomized Controlled Trials. Ann Vasc Surg. 2015 Oct;29(7):1457-67. Epub 2015 Jul 11. PMID: 26173202. https://doi.org/10.1016/j.avsg.2015.06.062

77. Lenz T. Behandlung der Nierenarterienstenose im Jahr 2021 Treatment of renal artery stenosis in the year 2021. Internist (Berl). 2021 Mar;62(3):252-262. German. PMID: 33459806. https://doi.org/10.1007/s00108-020-00935-5

78. Cambria RP, Brewster DC, L'Italien GJ, Moncure A, Darling RC Jr, Gertler JP, La Muraglia GM, Atamian S, Abbott WM. The durability of different reconstructive techniques for atherosclerotic renal artery disease. J Vasc Surg. 1994 Jul;20(1):76-85; discussion 86-7. https://doi.org/10.1016/0741-5214(94)90178-3

79. Senekowitsch C, Assadian A, Wlk MV, Assadian O, Ptakovsky H, Hagmüller GW. Renal artery surgery in the era of endovascular intervention. Vasa. 2004 Nov;33(4):226-30. https://doi.org/10.1024/0301-1526.33.4.226

80. Gornik HL, Persu A, Adlam D, Aparicio LS, Azizi M, Boulanger M et al. First International Consensus on the diagnosis and management of fibromuscular dysplasia. Vascular Medicine. 2019;24(2):164–89. https://doi.org/10.1177/1358863X18821816

81. Sang C.N., Whelton P.K., Hamper U.M. et al. Etiologic factors in renovascular fibromuscular dysplasia. A case-control study. Hypertension. 1989; 14: 472–9. https://doi.org/10.1161/01.hyp.14.5.472

82. Philipponnet C, Aniort J, Chabrot P, Souweine B, Heng AE. Renal artery thrombosis induced by COVID-19. Clin Kidney J. 2020;13:713. https://doi.org/10.1093/ckj/sfaa141

83. Olin J.W., Gornik H.L., Bacharach J.M. et al. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation. 2014;129:1048–78. https://doi.org/10.1161/01.cir.0000442577.96802.8c

84. McCormack L.J., Poutasse E.F., Meaney T.F. et al. A pathologic-arteriographic correlation of renal arterial disease. Am. Heart J. 1966;72:188–98. https://doi.org/10.1016/0002-8703(66)90442-x

85. Kadian-Dodov D, Gornik HL, Gu X, et al. Dissection and aneurysm in patients with fibromuscular dysplasia: Findings from the U.S. Registry for FMD. J Am Coll Cardiol. 2016;68:176–185. https://doi.org/10.1016/j.jacc.2016.04.044

86. Chazova I.E., Zhernakova Yu.V. Diagnosis and treatment of arterial hypertension Guidelines. Systemic Hypertension. 2019;16(1):6- 31. (in Russ.). https://doi.org/10.26442/2075082X.2019.1.190179

87. Stein LH, Berger J, Tranquilli M, et al. Effect of statin drugs on thoracic aortic aneurysms. Am J Cardiol. 2013;112:1240-1245. https://doi.org/10.1016/j.amjcard.2013.05.081

88. Catapano AL, Graham I, De Backer G, et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016;37:2999-3058. https://doi.org/10.1093/eurheartj/ehw272

89. Wang LC, Scott DJ, Clemens MS, et al. Mechanism of stent failure in a patient with fibromuscular dysplasia following renal artery stenting. Ann Vasc Surg. 2015;29:123.e19-21. https://doi.org/10.1016/j.avsg.2014.08.002

90. Raju MG, Bajzer CT, Clair DG, et al. Renal artery stent fracture in patients with fibromuscular dysplasia: A cautionary tale. Circ Cardiovasc Interv. 2013; 6:e30-31. https://doi.org/10.1161/circinterventions.113.000193

91. Colyer W.R., Eltahawy E., Cooper C.J. Renal artery stenosis: optimizing diagnosis and treatment. Prog. Cardiovasc. Dis. 2011; 54:29-35. https://doi.org/10.1016/j.pcad.2011.02.007

92. Lacombe M, Ricco JB. Surgical revascularization of renal artery after complicated or failed percutaneous transluminal renal angioplasty. J Vasc Surg. 2006; 44:537-544. https://doi.org/10.1016/j.jvs.2006.05.036

93. Kaplan NM, Victor RG. Kaplan’s Clinical Hypertension. Wolters Kluwer; 2015. P. 471.

94. Zaldivar Villon MLF, de la Rocha JAL, Espinoza LR. Takayasu arteritis: recent developments. Curr Rheumatol Rep. 2019;21:45. https://doi.org/10.1007/s11926-019-0848

95. Chikhladze N.M. Arterial hypertension in patients with non-specific aortoarteritis. Systemic Hypertension. 2018;15(2):43–48. https://doi.org/10.26442/2075-082X_2018.2.43-48

96. Saadoun D, Lambert M, Mirault T. Retrospective analysis of surgery versus endovascular Intervention in Takayasu arteritis. A multicenter experience. Circulation. 2012;125:813-9. https://doi.org/10.1161/circulationaha.111.058032

97. Korzets Z, Plotkin E, Bernheim J, Zissin R. The clinical spectrum of acute renal infarction. Isr Med Assoc J. 2002;4:781-784.

98. Pineo GF, Thorndyke WC, Steed BL. Spontaneous renal artery thrombosis: successful lysis with streptokinase. J Urol. 1987;138:1223–1225. https://doi.org/10.1016/s0022-5347(17)43557-9

99. Han M, Criado E. Renal artery stenosis and aneurysms associated with neurofibromatosis. J Vasc Surg. 2005;41:539–543. https://doi.org/10.1016/j.jvs.2004.12.021

100. Friedman JM, Arbiser J, Epstein JA, Gutmann DH, Huot SJ, Lin AE, McManus B, Korf BR. Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force. Genet Med. 2002;4:105–111. https://doi.org/10.1097/00125817-200205000-00002

101. Oderich GS, Sullivan TM, Bower TC, Gloviczki P, Miller DV, Babovic-Vuksanovic D, Macedo TA, Stanson A. Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results. J Vasc Surg. 2007;46:475–484. https://doi.org/10.1016/j.jvs.2007.03.055

102. Beladan CC, Geavlete OD, Botezatu S, Postu M, Popescu BA, Ginghina C, Coman IM. Revascularization in a 17-Year-old girl with neurofibromatosis and severe hypertension caused by renal artery stenosis. Tex Heart Inst J. 2017;44:50–54. https://doi.org/10.14503/THIJ-15-5466

103. Kurien A, John PR, Milford DV. Hypertension secondary to progressive vascular neurofibromatosis. Arch Dis Child. 1997;76:454–455. https://doi.org/10.1136/adc.76.5.454

104. Raborn J, McCafferty BJ, Gunn AJ, Moawad S, Mahmoud K, Aal AKA, Saddekni S. Endovascular management of neurofibromatosis type I-associated vasculopathy: a case series and brief review of the literature. Vasc Endovascular Surg. 2020;54:182-190. https://doi.org/10.1177/1538574419885257

105. Tullus K, Brennan E, Hamilton G, Lord R, McLaren CA, Marks SD, Roebuck DJ. Renovascular hypertension in children. Lancet. 2008;371:1453–1463. https://doi.org/10.1016/S0140-6736(08)60626-1

106. Reginelli A, Somma F, Izzo A, Urraro F, D'Andrea A, Grassi R, Cappabianca S. Renovascular anatomic variants at CT angiography. Int Angiol. 2015 Dec;34(6 Suppl 1):36-42. PMID: 26498890.

107. Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Falkner B, Flinn SK, et al; Subcommittee on Screening and Management of High Blood Pressure in Children. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140:e20171904. https://doi.org/10.1542/peds.2017-1904

108. Grange DK, Balfour IC, Chen SC, Wood EG. Familial syndrome of progressive arterial occlusive disease consistent with fibromuscular dysplasia, hypertension, congenital cardiac defects, bone fragility, brachysyndactyly, and learning disabilities. Am J Med Genet. 1998;75:469–480. https://doi.org/10.1002/(sici)1096-8628(19980217)75:5%3C469::aid-ajmg4%3E3.0.co;2-i

109. Srinivasan A, Krishnamurthy G, Fontalvo-Herazo L, Nijs E, Keller MS, Meyers K, Kaplan B, Cahill AM. Angioplasty for renal artery stenosis in pediatric patients: an 11-year retrospective experience. J Vasc Interv Radiol. 2010;21:1672–1680. https://doi.org/10.1016/j.jvir.2010.07.012

110. Rimoldi SF, Scherrer U, Messerli FH. Secondary arterial hypertension: when, who, and how to screen? Eur Heart J. 2014 May 14;35(19):1245-54. Epub 2013 Dec 23. PMID: 24366917. https://doi.org/10.1093/eurheartj/eht534

111. Fomin V.V., Kupriyanov I.E., Razuvaeva M.A. Multiple renal arteries – an epiphenomena or potential cause of arterial hypertension? Clinical Nephrology. 2012; 5-6:64-67.

112. Markova T.N., Parshin V.V., Mishchenko N.K. Secondary hyperaldosteronism, caused by abnormalities of the renal vessels, in clinical endocrinologist. Endocrine Surgery. 2016;10(1):28-34. (In Russ.). https://doi.org/10.14341/serg2016128-34

113. Halpern EJ, Nazarian LN, Wechsler RJ, Mitchell DG, Outwater EK, Levin DC, Gardiner GA Jr, Feldman HI. US, CT, and MR evaluation of accessory renal arteries and proximal renal arterial branches. Acad Radiol. 1999 May;6(5):299-304. PMID: 10228619. https://doi.org/10.1016/s1076-6332(99)80453-x

114. Chazova I.E., Danilov N.M., Litvin A.Yu. Refractory arterial hypertension: Monograph. M.: Publishing house «Atmosfera», 2014. p. 254 (in Russ.). ISBN 978-5- 902123-61-3

115. Aliev E. MR angiography in the diagnosis of mesenteric and limb vessels: clinical cases. – URL: https://msk.mrtexpert.ru/articles/202 (in Russ.).